[ad_1]
TO December 21 Places meeting for Pfizer / BioNTech vaccine approval the European Medicines Agency (Coreper), as stated in a statement issued Tuesday.
After receiving additional data requested by the EMA Committee for Medicines (CHMP) from the company yesterday, Monday afternoon and awaiting the result of its evaluation, an extraordinary meeting of the CHMP is scheduled for 21 December, with in order to make a decision. , If possible. “The meeting scheduled for December 29 will be held if necessary,” the EMA said in a statement.
According to Coreper, as soon as the competent committee gives a “green light”, the Commission will “execute” the decision-making process with a view to granting a marketing authorization in a few days.
‼ ️ Update on the evaluation of the BioNTech and Pfizer BNT162b2 vaccine marketing authorization application: https://t.co/7UbMtZn8eK
– EU Medicines Agency (@EMA_News) December 15, 2020
In this direction also showed the President of the Commission, Ursula von der Leyen.
In a Twitter post, he noted that “every day counts” and added that “we are working at full speed to approve safe and effective vaccines against coronavirus.”
The Chairman of the Commission welcomed Coreper’s decision to speed up the proceedings, scheduling their meeting for the Pfizer / BioNTech vaccine before Christmas. “It is possible that the first Europeans are vaccinated before the end of 2020,” he said.
Every day counts: we work at full speed to authorize # COVID-19 vaccines that are safe and effective.
I welcome @EMA_News moving forward their meeting to discuss the vaccine @ pfizer / BioNTech, before Christmas.
The first Europeans are likely to be vaccinated before the end of 2020!
– Ursula von der Leyen (@vonderleyen) December 15, 2020
It is recalled that the European authorities had originally marked a milestone for authorization on 29the December, as the last potential date. However, after approval from Great Britain and the United States, the pressures intensified.
After all, today’s Bild article spoke decision of December 23, date that was put on the table and officially, later, and the German Minister of Health, Jens Span.
[ad_2]
